LexDanaLexDanabeta
Inventor

Paul RAKESH

Inventor
IN

Overview

3→
Patents
2023–2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
C07DHeterocyclic compounds38%
A61KPreparations for medical, dental or toiletry purposes25%
PatentTitleYear
12,016,852Pyrrolidine glycosidase inhibitors202411,795,165Tetrahydro-benzoazepine glycosidase inhibitors202311,731,972Spiro compounds as glycosidase inhibitors2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023–2024Patents assigned to ASCENEURON SA (3)· patent assignee history
2023–2024Based in IN· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ASCENEURON SA32023–2024
Locations
LocationPatentsSpan
IN32023–2024